Steven R. Caliari is an Associate Professor in the Department of Chemical Engineering with a secondary appointment in Biomedical Engineering at the University of Virginia’s School of Engineering and Applied Science. He serves as the ChE Graduate Program Director and is a SEAS Copenhaver Fellow (2023). His research focuses on designing biomaterials to study cell-microenvironment interactions, addressing challenges in disease and tissue engineering. He holds a B.S. (2007, University of Florida), M.S. (2010), and Ph.D. (2013) in Chemical Engineering from the University of Illinois, followed by an NIH postdoctoral fellowship at the University of Pennsylvania. His research interests include biomaterials, mechanobiology, musculoskeletal tissue engineering, and advanced manufacturing for biological applications. His lab has pioneered viscoelastic hydrogel platforms and conductive collagen scaffolds, supported by NIH, NSF, DoD, and industry grants. Notable awards include the NSF CAREER Award (2021) and NIH MIRA (2020). Grants: NIH (NIGMS), NSF CAREER, V Foundation, UVA-Coulter Partnership Courses: Tissue Engineering (BME/CHE 4417), Transport Processes I (CHE 3321) Labs: Caliari Lab focuses on biomaterial design and mechanobiological studies His work bridges fundamental science and translational applications, emphasizing dynamic material systems for regenerative medicine and disease modeling.
Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.
Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.
Michael Vershinin is an Assistant Professor of Physics and Astronomy at the University of Utah, specializing in molecular motors and biophysics. He is also affiliated with the Biological Chemistry Program and leads a lab focused on understanding how molecular motors like kinesin and dynein drive intracellular transport and viral assembly. He earned his B.S. from Cooper Union College and Ph.D. from the University of Illinois, Urbana-Champaign. His research interests include: Molecular motor function and regulation Single-molecule biophysics Microtubule-based transport Viral particle assembly (especially SARS-CoV-2 and HIV) Optical trapping and fluorescence microscopy His lab uses in vitro reconstitution and optical trapping to dissect the biophysical properties of motor proteins and their regulation. He collaborates across disciplines, integrating biochemistry, molecular biology, physics, and computational modeling to explore how complex biological behaviors emerge from simpler components. His publications span a wide range of topics, from the structural stability of SARS-CoV-2 virus-like particles to the mechanical behavior of kinesin and dynein motors. A recurring theme is the use of quantitative biophysical tools to understand how motor proteins navigate complex cytoskeletal environments and how viruses hijack these systems for transport. He currently advises no listed students in the provided text and has not received any explicitly listed awards. His lab is located at the University of Utah and can be reached at vershinin@physics.utah.edu .
Frida Hållenius is an Associate Professor and Senior Lecturer in Molecular Nutrition at the Division of Food and Pharma, Faculty of Engineering (LTH), Lund University. She is a key member of the LTH Profile Area: Food and Bio and leads or actively participates in multiple research projects exploring the role of diet and gut microbiota in human health. Associate Professor in Molecular Nutrition Senior Lecturer, Division of Food and Pharma Faculty of Engineering (LTH), Lund University Principal Investigator, Gut Microbiome Laboratory (GML) Active researcher in 3 ongoing projects, including NeuroFood and ScanOats Her research is centered on host-microbiota interactions, particularly how dietary components, probiotics, and polyphenols influence gut health, inflammation, metabolic diseases, and neuroinflammation. Her work bridges nutrition, microbiology, and neuroscience, with a strong focus on preventive strategies for lifestyle-related diseases such as obesity, diabetes, and Alzheimer’s disease. She employs both animal models (e.g., C57BL/6, Apoe-/- mice) and human-relevant in vitro systems to study dietary interventions. The recent trends in her publications highlight a strong focus on the gut-brain axis, the impact of Nordic berries and legumes on microbiota and metabolic health, and the use of advanced models like 3D intestinal tissue. Her work often involves interdisciplinary collaboration and contributes to multiple UN Sustainable Development Goals, particularly those related to good health and well-being. Scientific Awards: No specific awards mentioned in the provided text. She has supervised several junior researchers and students, including research students and assistants, and is actively involved in grant-funded research projects from FORMAS and private foundations. She leads the Gut Microbiome Laboratory (GML), a collaborative research environment focused on understanding how diet shapes the gut microbiome and influences disease pathways. Her leadership in projects like NeuroFood and those targeting Alzheimer’s disease underscores her commitment to translational nutritional science.
Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement
Prof. Dr. Marc Schneider holds a professorship in Biopharmaceutics and Pharmaceutical Technology at Saarland University's College of Pharmacy . His research focuses on colloidal drug delivery systems, particularly nanostructured and non-spherical particle engineering for overcoming biological barriers in pulmonary and transdermal applications. He leads an internationally recognized lab in Saarbrücken, collaborating with Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and trinational institutions. Research Highlights: Development of inhalable nano/microparticle systems Surface modification of gelatin nanoparticles Characterization of mucus-penetrating particles 3D printing for microneedle fabrication Atomic Force Microscopy (AFM) for nanoparticle analysis Selected Scientific Awards: European Journal of Pharmaceutics and Biopharmaceutics Best Paper Award (2018) for mucus-penetrating nanoparticles Recognized in 'Ausgezeichnete Orte im Land der Ideen' competition (2018) for 'Nano-Mais' drug delivery system Collaborative Networks: Co-editor for Advanced Drug Delivery Reviews special issue on biological barriers Key participant in trinational Master's program in Biomedicine with Strasbourg, Mainz, and Luxembourg Active in Controlled Release Society (CRS) conferences and local chapters
João F. Mano is a Full Professor at the Department of Chemistry, University of Aveiro, and Director of the Doctoral Program on Biotechnology. He leads the COMPASS Research Group and serves as Vice-Director at CICECO - Aveiro Institute of Materials. His academic appointments include Invited Professor at University of Lorraine (France), Visiting Professor at KAIST (South Korea), and Adjunct Professor at Ajou University (South Korea). Education: PhD in Chemistry (1996, Technical University of Lisbon); D.Sc. in Tissue Engineering, Regenerative Medicine and Stem Cells (2012, University of Minho) Research Interests focus on Biomaterials for Regenerative Medicine , integrating Nanotechnology , Microtechnology , and Biofabrication . His group develops Bioinspired Materials using polymer chemistry, Decellularized Extracellular Matrix , and 3D Bioprinting to engineer Cell Microenvironments for therapeutic applications. Recent Publications highlight advancements in Human-Derived Hydrogels , Photopolymerizable Scaffolds , Magneto-Responsive Biomaterials , and Programmable Bioinks . Trends show emphasis on Organ-on-a-Chip integration, Smart Living Materials , and Green Bioprinting methodologies. Scientific Awards include: European Research Council Advanced Grants (2015, 2020) Fellow at IUPAC, European Academy of Sciences, and American Institute of Medical and Biological Engineering ERC Proof of Concept Grants Doctor Honoris Causa from University of Lorraine and Utrecht UNESCO Chair on Biomaterials George Winter Award (European Society for Biomaterials) Supervisions & Collaborations encompass 74+ MSc, 26+ PhD students, and 40+ postdocs. He co-founded METATISSUE and CELLULARIS Biomodels , and serves as Editor-in-Chief of Materials Today Bio .
Jouni Hirvonen is a Professor in the Division of Pharmaceutical Chemistry and Technology at the University of Helsinki's Faculty of Pharmacy. He serves as Supervisor for doctoral programmes in both the Doctoral Programme in Drug Research and the Doctoral Programme in Materials Research and Nanosciences. With an extensive publication record spanning over three decades, Hirvonen has contributed 384 research outputs and participated in 3 major research projects. His research interests focus on pharmaceutical technology, particularly in drug delivery systems, nanoparticles, and drug dissolution and absorption. His work bridges pharmaceutical chemistry with cutting-edge nanotechnology applications, developing innovative delivery systems for therapeutic agents. His research spans from fundamental pharmaceutical sciences to translational applications in regenerative medicine, immunotherapy, and cardiovascular pharmacology. The analysis of his recent publications reveals a strong focus on advanced drug delivery platforms, particularly utilizing nanoparticles, lipid-based systems, and biomaterials for targeted delivery. His work increasingly integrates microfluidic technology for precise nanoparticle preparation, with applications spanning cancer immunotherapy, cardiovascular repair, tendon regeneration, and inflammatory disease treatment. The trend shows a growing emphasis on combination therapies, RNA delivery, and cell-mediated drug delivery approaches. Hirvonen has received several prestigious awards throughout his career: CRS/Eurand Grand Prize Award on Innovations in Oral Drug Delivery Technologies (2007) Suomen Valkoisen Ruusun Ritarikunnan I luokan ritarimerkki (2013) The Young Scientist in the University of Kuopio (1993) University of Helsinki Quality Teaching Unit, Faculty of Pharmacy (2005) Visiting Professor award (2015) With 25 instances of supervising doctoral theses and numerous academic activities including conference organization, committee memberships, and editorial work, Hirvonen has made significant contributions to academic mentorship and institutional development. His research has been supported by projects including Generation Green, 3i REGENERATION, and IVIVRe. His work appears to involve collaboration with multiple research teams focusing on drug delivery applications across various therapeutic areas.
Dr. Joanna Deaton Bertram is an Assistant Professor in the Thomas Lord Department of Mechanical Engineering and Materials Science at Duke University’s Pratt School of Engineering. She concurrently holds an Assistant Professor appointment in Surgery, underscoring her interdisciplinary commitment to advancing medical robotics. Dr. Bertram leads a research laboratory devoted to the design, modeling, and control of robotic systems for surgical and interventional applications, working closely with Duke’s clinical and engineering communities. Education Ph.D. in Robotics, Georgia Institute of Technology, 2024 M.S. in Mechanical Engineering, Georgia Institute of Technology, 2024 B.S. in Biomedical Engineering, Georgia Institute of Technology, 2018 Research Interests Dr. Bertram’s research program is centered on medical robotics , with particular emphasis on continuum robotics and image-guided interventions . Her work integrates novel mechanical design with advanced control algorithms and smart materials to create robotic systems capable of navigating complex anatomical pathways. A hallmark of her approach is the incorporation of real-time fiber-optic shape and force sensing (using Fiber Bragg Grating technology) to provide surgeons with unprecedented feedback during procedures. Application domains include steerable needles for brachytherapy , robotic guidewires for endovascular surgery , and pediatric neuroendoscopy . Publication Themes Across more than fifteen peer-reviewed articles, Dr. Bertram has systematically advanced the state of the art in surgical robotics , fiber-optic sensing , and robotic system modeling . Her 2024 tutorial on Nitinol and Tungsten tendon attachment techniques provides practical guidance for building highly articulated continuum robots, while her 2023 series on the COAST guidewire robot demonstrates model-based design and simultaneous shape/force sensing for large-deflection medical devices. Earlier work explored 3D-printed patient-specific robotic tools and carbon-nanotube flexible sensors, illustrating a trajectory from fundamental sensor research to full robotic system integration. Scientific Recognition & Collaboration Although no major external awards are explicitly listed, Dr. Bertram’s publications in top-tier venues such as IEEE Robotics and Automation Letters , IEEE Transactions on Medical Robotics and Bionics , and IEEE/ASME Transactions on Mechatronics attest to strong peer recognition. She actively invites motivated graduate students, post-docs, and research staff to join her lab, fostering an open and interdisciplinary environment. Advising & Grants Dr. Bertram’s lab is presently recruiting trainees at all levels. While specific funded grants are not enumerated, her dual departmental appointments and extensive publication record suggest active federal or foundation support. Prospective students and collaborators are encouraged to contact her directly at joanna.d.bertram@duke.edu . Laboratory & Teams Dr. Bertram directs a laboratory within Duke University’s Pratt School of Engineering that collaborates closely with clinicians in the School of Medicine. The group focuses on rapid prototyping of medical devices, in-vitro and ex-vivo validation, and translation of robotic technologies to the operating room.
Gianmarco Pinton is an Associate Professor in the Department of Biomedical Engineering at the University of North Carolina at Chapel Hill. His research focuses on nonlinear ultrasound and mechanical wave propagation, with applications to medical imaging and therapy. He specializes in traumatic brain injury, shear shock waves, and ultrasound therapy. Ph.D., M.S., and B.S.E. in Biomedical Engineering/Physics from Duke University His lab develops physics and simulation tools for nonlinear wave propagation, aiming to create advanced diagnostic ultrasound methods. Key areas include traumatic brain injury, transcranial imaging, and therapeutic ultrasound. His recent work explores super-resolution imaging, brain motor circuits, and Alzheimer's disease vascular mapping using ultrasound. Article trends highlight innovations in transcranial ultrasound, super-resolution techniques, lung imaging, and neuromodulation. His publications address image degradation, contrast agents, and shear wave dynamics in neurological contexts.
Dr. Alison Holloway is a Professor at McMaster University's Faculty of Health Sciences, specializing in environmental toxicology and reproductive health. Her research focuses on the effects of environmental contaminants (e.g., oil sands pollutants, pesticides, endocrine disruptors) on maternal and child health, metabolic disorders, and developmental outcomes. She has conducted studies on naphthenic acids, synthetic food additives, and maternal exposure to pharmaceuticals like fluoxetine. Key research areas include: Environmental contaminants' impact on reproductive systems and placental function Metabolic disturbances caused by chemical exposures during critical developmental windows Neurobehavioral and gastrointestinal effects of prenatal drug exposure Assessment of urban air pollution on in vitro fertilization (IVF) success rates Her recent work highlights the role of the tryptophan-kynurenine pathway as a biomarker of environmental stress and the obesogenic effects of bisphenol analogs and food additives. Collaborations involve interdisciplinary teams addressing environmental health, with studies published in high-impact toxicology and public health journals. Dr. Holloway's research has informed policies on chemical safety and maternal health, emphasizing cross-species markers for organismal health and risk assessment of emerging contaminants like cannabis derivatives.
Associate Professor Khoon Lim is a biomedical engineer specializing in polymer chemistry and biomaterials, affiliated with the School of Medical Sciences at the University of Sydney. He holds a PhD in Biomedical Engineering from UNSW Sydney and has conducted postdoctoral research at the University of Otago. His research focuses on hydrogels for tissue engineering, 3D bioprinting, and regenerative medicine, with over $8M in grant funding. Lim leads the Light Activated Biomaterials (LAB) research group and is a member of prestigious organizations like the Australasian Society for Biomaterials and Tissue Engineering. Education: BE (Chemical Engineering, Hons 1) and ME (Biomedical Engineering) from UNSW Sydney, followed by a PhD in Biomedical Engineering (2014). Postdoctoral fellowship at University of Otago Christchurch (2019). Research Interests: Biofabrication, 3D bioprinting, hydrogels for tissue regeneration, cardiovascular applications, and chronic disease management. Current projects include developing bioinks for functional tissues, smart delivery systems for growth factors, and cancer models for drug screening. Key Achievements: ARC Future Fellow (2022), Rutherford Discovery Fellowship (2021), and over 170 publications in journals like Advanced Materials and Biofabrication . Holds patents in hydrogel technologies. Leadership Roles: President of ASBTE, Board Member of ISBF, and editorial board positions in journals such as RSC Biomaterials Science . Active in translational research through collaborations in Australia, New Zealand, Europe, and Asia.
Adam Feinberg is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University (CMU). He leads the Regenerative Biomaterials & Therapeutics Group, focusing on cell-material interactions, 3D bioprinting, and bioengineered tissues. His work integrates nanofabrication, molecular biology, and 3D imaging to address challenges in muscle repair, corneal regeneration, and cancer. Key innovations include the FRESH bioprinting platform, enabling soft ECM gel-based constructs, and ECM shrink-wrapping techniques for cell encapsulation. Feinberg holds a Ph.D. and MS in Biomedical Engineering from the University of Florida (2004, 2002) and a BS in Materials Science and Engineering from Cornell University (1999). He has secured major grants, including ARPA-H funding for diabetes treatments and Canada’s New Frontiers Fund for heart disease therapies. His research has led to over 45 peer-reviewed articles and 20 patents. His scientific awards include the NIH Director’s New Innovator Award and NSF CAREER Award. Media highlights include breakthroughs in vascularized tissue models and biodegradable actuators. Feinberg collaborates widely, advancing clinical translation of bioprinted tissues and sustainable bio-bots.
Christos Tapeinos is a Lecturer in Pharmaceutical Sciences at the University of Manchester, specializing in pharmaceutical nanotechnology for treating brain diseases (e.g., glioblastoma, neuroinflammation) and pancreatic cancer. His research focuses on developing smart nanomedicines, advanced in vitro models (e.g., fluidic systems mimicking brain environments), and stimuli-responsive nanomaterials to overcome biological barriers like the blood-brain barrier. He leads the development of skin-mimicking models for subcutaneous drug delivery as a Co-Investigator in the HALo program. Education: Docent in Pharmaceutical Nanotechnology (2022) PhD in Materials Science (2013) MSc in Materials Science (2010) BSc in Materials Science (2006) Research Interests: Drug delivery systems, nanoparticle engineering, in vitro disease models, biomimetic materials, and translational nanomedicine. He integrates nanotechnology with precision medicine to address complex diseases. Recent Articles Trends: Focus on nanoparticle-cell interactions, phototherapy systems, graphene-cerium oxide hydrogels, and targeted theranostics. Highlights include ROS-scavenging systems and multi-stage nanovectors for CNS pathologies. Awards: Marie Skłodowska-Curie Actions Fellowship. Grants/Projects: Supported by EPSRC, The Royal Society, and Translation Manchester. Active in the Hub for Long-Acting Technologies (2024–2030). Labs/Teams: Leads research groups developing fluidic BBB models, skin-mimicking drug diffusion systems, and nanomaterial-based therapies.
